Governing biotechnology to provide safety and security and address ethical, legal, and social implications

Abstract

The field of biotechnology has produced a wide variety of materials and products which are rapidly entering the commercial marketplace. While many developments promise revolutionary benefits, some of them pose uncertain or largely untested risks and may spur debate, consternation, and outrage from individuals and groups who may be affected by their development and use. In this paper we show that the success of any advanced genetic development and usage requires that the creators establish technical soundness, ensure safety and security, and transparently represent the product’s ethical, legal, and social implications (ELSI). We further identify how failures to address ELSI can manifest as significant roadblocks to product acceptance and adoption and advocate for use of the “safety-by-design” governance philosophy. This approach requires addressing risk and ELSI needs early and often in the technology development process to support innovation while providing security and safety for workers, the public, and the broader environment. This paper identifies and evaluates major ELSI challenges and perspectives to suggest a methodology for implementing safety-by-design in a manner consistent with local institutions and politics. We anticipate the need for safety-by-design approach to grow and permeate biotechnology governance structures as the field expands in scientific and technological complexity, increases in public attention and prominence, and further impacts human health and the environment.

Synthetic biology regulation in Europe: containment, release and beyond

“…Future uses of cell-free synthetic biology will need to attend to dimensions of responsibility beyond solely what is ‘legal’, while they negotiate the inevitable uncertainties. This can be done through a variety of processes that implement responsible research and innovation , be that safety-by-design ( 22 ), midstream modulation ( 48 ) (or anticipatory governance ( 49 ).…”

“…The polycarbonate shell’s melting temperature was higher than the inactivation temperature of B. subtilis , thus minimizing release risk even if the plastic was compromised by exposure to heat. Each of these innovations can be seen as examples of safety-by-design: a process by which ‘through technical or procedural interventions, potential technology hazards are removed early in the development process and evaluated iteratively throughout development’ ( 22 ).…”

The need for communication between researchers and policymakers for the deployment of bioengineered carbon capture and sequestration crops

“…This paper focuses on the US, but other nations will have unique qualities that affect the deployment of BE/GEd-CCS crops. Going forward, systems-wide frameworks like the Responsible Research and Innovation or Ethical, Legal, and Social Implication frameworks could help evaluate the development and implementation of BE/GEd-CCS crops (Stilgoe et al, 2013;Trump et al, 2023). Lastly, researchers can explore publics' opinions on BE/GEd-CCS crops since including the opinions of different groups are needed for the democratic governance of a technology (Stilgoe et al, 2014).…”

Integrating MLSecOps in the Biotechnology Industry 5.0

“…As the biotechnology industry supports critical sectors such as food, agriculture, healthcare, pharmaceuticals, and energy, companies must stay current with industry standards. Maintaining integrity, security, proper regulations, and ethical policies remain paramount to ensure responsible development and use of biotechnologies across industries [7]. Massive amounts of data in various biotechnology sectors (e.g., bioengineering, biodefense, forensics) have resulted in the deployment of technological solutions-big data, IoT, and AI in biotechnology.…”